Arbutus Biopharma Statistics
Total Valuation
ABUS has a market cap or net worth of $495.48 million. The enterprise value is $371.25 million.
| Market Cap | 495.48M |
| Enterprise Value | 371.25M |
Important Dates
The next confirmed earnings date is Thursday, May 2, 2024, before market open.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ABUS has 180.18 million shares outstanding. The number of shares has increased by 9.95% in one year.
| Shares Outstanding | 180.18M |
| Shares Change (YoY) | +9.95% |
| Shares Change (QoQ) | +0.64% |
| Owned by Insiders (%) | 23.34% |
| Owned by Institutions (%) | 43.92% |
| Float | 115.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 27.31 |
| Forward PS | 55.52 |
| PB Ratio | 4.67 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 20.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.87, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.87 |
| Quick Ratio | 5.68 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -157.71 |
Financial Efficiency
Return on equity (ROE) is -57.80% and return on invested capital (ROIC) is -72.40%.
| Return on Equity (ROE) | -57.80% |
| Return on Assets (ROA) | -43.40% |
| Return on Capital (ROIC) | -72.40% |
| Revenue Per Employee | $248,507 |
| Profits Per Employee | -$997,932 |
| Employee Count | 73 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.84% in the last 52 weeks. The beta is 2.09, so ABUS's price volatility has been higher than the market average.
| Beta (1Y) | 2.09 |
| 52-Week Price Change | -4.84% |
| 50-Day Moving Average | 2.77 |
| 200-Day Moving Average | 2.27 |
| Relative Strength Index (RSI) | 48.30 |
| Average Volume (30 Days) | 1,437,708 |
Short Selling Information
The latest short interest is 4.55 million, so 2.52% of the outstanding shares have been sold short.
| Short Interest | 4.55M |
| Short Previous Month | 4.13M |
| Short % of Shares Out | 2.52% |
| Short % of Float | 3.93% |
| Short Ratio (days to cover) | 7.05 |
Income Statement
In the last 12 months, ABUS had revenue of $18.14 million and -$72.85 million in losses. Loss per share was -$0.44.
| Revenue | 18.14M |
| Gross Profit | 18.14M |
| Operating Income | -78.03M |
| Pretax Income | -72.85M |
| Net Income | -72.85M |
| EBITDA | -70.99M |
| EBIT | -72.39M |
| Loss Per Share | -$0.44 |
Balance Sheet
The company has $126.00 million in cash and $1.77 million in debt, giving a net cash position of $124.24 million or $0.69 per share.
| Cash & Cash Equivalents | 126.00M |
| Total Debt | 1.77M |
| Net Cash | 124.24M |
| Net Cash Per Share | $0.69 |
| Equity / Book Value | 106.02M |
| Book Value Per Share | 0.59 |
| Working Capital | 109.54M |
Cash Flow
In the last 12 months, operating cash flow was -$85.94 million and capital expenditures -$988,000, giving a free cash flow of -$86.92 million.
| Operating Cash Flow | -85.94M |
| Capital Expenditures | -988,000 |
| Free Cash Flow | -86.92M |
| FCF Per Share | -$0.52 |
Margins
Gross margin is 100.00%, with operating and profit margins of -430.15% and -401.57%.
| Gross Margin | 100.00% |
| Operating Margin | -430.15% |
| Pretax Margin | -401.57% |
| Profit Margin | -401.57% |
| EBITDA Margin | -391.30% |
| EBIT Margin | -399.04% |
| FCF Margin | -479.16% |
Dividends & Yields
ABUS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.95% |
| Shareholder Yield | -9.95% |
| Earnings Yield | -14.70% |
| FCF Yield | -17.54% |
Analyst Forecast
The average price target for ABUS is $4.33, which is 57.46% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.33 |
| Price Target Difference | 57.46% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 31.83% |
| EPS Growth Forecast (5Y) | -20.81% |
Stock Splits
The last stock split was on November 4, 2010. It was a reverse split with a ratio of 1:5.
| Last Split Date | Nov 4, 2010 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
ABUS has an Altman Z-Score of -5.25 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.25 |
| Piotroski F-Score | 2 |